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Purpose: To analyse prognostic features on quality of life (QoL) following radical cys-
tectomy and urinary diversion via orthotopic neobladder in a single-centre patient 
cohort.
Materials and Methods: Postoperative QoL of 152 patients was assessed retrospectively 
using the validated QLQ-C30 questionnaire. Potential associations of patient’s quality 
of life including pre-and intraoperative characteristics, surgeon experience, postopera-
tive time course, adjuvant therapies, and functional outcome were defined a priori and 
evaluated. Mann-Whitney-U-, Kruskal-Wallis-, Spearman correlation and post hoc-
testing were used. A multivariate analysis using a multiple logistic regression model 
was performed. A p value <0.05 was considered to be statistically significant.
Results: Median follow-up was 48 months. Univariate analysis of prognostic features 
for health-related QoL revealed a significant impact of gender (p=0.019), performance 
status (p<0.001), experience of surgeon (>100 previous cystectomies, p=0.007), and 
nerve-sparing surgery (p=0.001). Patients who underwent secondary chemotherapy or 
radiotherapy had significant lower QLQ-C30 scores (p=0.04, p=0.02 respectively). Pa-
tients who were asymptomatic had a significantly higher quality of life (p<0.001). A 
significant impact of severity of incontinence based on ICIQ-SF score (p<0.001) and 
daily pad usage (p<0.001), existence of daytime incontinence (p<0.001), existence of 
urgency symptoms (p=0.007), and IIEF-5 score (p<0.001) could be observed. In multi-
variate analysis, independent prognostic relevance could be confirmed for preoperative 
ECOG performance status of 0 (p=0.020 vs. ECOG 1, p=0.047 vs. ECOG 2), experience 
of the respective surgeon (≥100 vs. <100 previous cystectomies, p=0.021), and daytime 
continence (p=0.032).
Conclusion: In the present study, we report health-related QoL outcomes in a contem-
porary patient cohort and confirm preoperative ECOG status, surgeon experience and 
daytime incontinence as independent prognostic features for a good postoperative QoL.
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InTRODucTIOn
Bladder cancer is the second most common 
malignancy in the urinary tract and transitional 
cell carcinoma of the urinary bladder is currently 
the fourth most common malignancy in men in 
the Western world (1). Neoadjuvant chemotherapy, 
followed by radical cystectomy, extended pelvic 
lymphadenectomy, and urinary diversion (using 
an ileal conduit or ileal orthotopic neobladder) is 
the gold standard therapeutic approach for muscle 
invasive bladder cancer (2). However, radical cys-
tectomy comes along with quite a burden for the 
patient considering a long-term morbidity-rate of 
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up to 90% leading to a considerable mortality rate 
(3-5). Recently, there was an increasing interest 
in QoL aspects for patients undergoing radical 
cystectomy, mostly regarding different types of 
urinary diversion (6). While short-term and long-
-term complications and long-term functional 
outcomes after urinary diversion via orthotopic 
neobladder have been extensively analysed the-
re is still a lack of data concerning QoL aspects. 
Functional outcomes have been described to sig-
nificantly influence the patient’s QoL after ortho-
topic urinary diversion, but little is known about 
further possible influencing factors (7). Thus, the 
aim of this study is to investigate various potential 
contributing factors on patient’s QoL after radical 
cystectomy and urinary diversion via orthotopic 
neobladder.
MATERIALs AnD METhODs
Patient population, study design and data as-
sessment
In one tertiary care centre, 301 cystecto-
mies with urinary diversion via orthotopic neo-
bladder were performed between May 2004 and 
September 2014 by a total number of 14 surgeons. 
During follow-up period, 92 patients had died. 
After approval by an institutional review board, 
data assessment was performed retrospectively via 
standardized questionnaires that were sent to 209 
patients who underwent radical cystectomy and 
urinary diversion via orthotopic neobladder due 
to malignancy. Questionnaires were returned by 
152 patients and underwent further analysis. This 
leads to a global response rate of 50.5%.
Health-related QoL was measured using 
the standardized EORTC QLQ-C30 (global he-
alth status; validated German version) (8). The 
global health status was calculated follo-
wing current EORTC instructions: score=100* 
[(question29+question30)/2–1]/6 (9). This indica-
tes that higher scores are associated with an in-
creased QoL.
Potential predefined prognostic features 
of patient’s QoL were evaluated. Hereby we focu-
sed on various categories including preoperative 
characteristics (gender, preoperative age, perfor-
mance status), intraoperative features (surgeon’s 
experience, nerve sparing operation, operation 
duration, blood loss, blood transfusion, postope-
rative revision, postoperative complications), TNM 
classification, functional outcome (continence 
status, urgency symptoms, sexual function), adju-
vant therapies (chemotherapy, radiotherapy), and 
symptoms (any symptoms, night sweats, weight 
loss, flank pain).
The preoperative performance status was 
determined based on the respective Eastern Co-
operative Oncology Group performance (ECOG) 
status score (10).
Daytime continence was determined using 
the validated International Consultation on Incon-
tinence Questionnaire (ICIQ) short-form scoring 
system in a validated German translation, and 
pad usage (11). The existence of urgency symp-
toms was assessed. Depending on the respective 
ICIQ-SF, patient’s stress urinary incontinence was 
classified as mild (1-5), moderate (6-10), and seve-
re (>10) as previously described (11).
Sexual function was assessed using the 
abridged International Index of Erectile Function 
(IIEF-5) (12) and abridged Female Sexual Function 
Index (FSFI-6) (13) respectively. A cut-off score of 
>20 (out of 25) points was used as the definition of 
potency as previously described (12). Female sexu-
al dysfunction was defined by a FSFI-6 of less than 
18 as previously described by Isidori et al. (13).
statistical analysis
Primary endpoint was the QoL (global he-
alth status based on EORTC QLQ-C30 questions 29 
and 30) of the respective patient. Secondary end-
points were above-mentioned prognostic features. 
Analysis was performed using the global health 
status as a continuous variable as well as using a 
cut-off score of 70 as recently described by Snyder 
et al. (14). Hereby, a QLQ-C30 score of less than 
70 is associated with a poor quality of life, a score 
of at least 70 is considered to be associated with a 
good quality of life.
To analyse and compare QoL in the res-
pective subgroups, Mann-Whitney-U-, Kruskal-
-Wallis-ANOVA, and chi-squared-Test, Spearman’s 
rank correlation, and post-hoc-testing were used 
whenever indicated. Additionally, a multiple lo-
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gistic regression model that included all potential 
prognostic features that showed significant results 
in the univariate analysis was performed. All sta-
tistical analyses were performed using STATISTICA 
10 software (StatSoft, Tulsa, OK, USA). A p value 
<0.05 was considered to be statistically significant.
REsuLTs
Pre-and perioperative patient characteristics
Median follow-up, defined as time be-
tween radical cystectomy and answering of the 
questionnaire, was 48 months [3-108]. Follow-up 
was within the first 12 months in 22% (n=33) 
of the patient collective. Median patient age was 
71 years [44-88 years]. Patient characteristics of 
the patients that underwent further analysis are 
summarized in Table-1.
Analysis responder vs. non-responder
To analyse for a potential selection bias, we 
compared preoperative characteristics and patho-
logical tumour stage for those patients who res-
ponded to the questionnaire and those who did not 
respond. Among the patients who did not respond 
to the questionnaire, 56% were deceased. Median 
Table 1 - Baseline patients characteristics, histopathologic results, and stated symptoms following radical cystectomy and 




Age at follow-up (years) 

















Flank pain 15.1% (22/146)
Night sweats 6.2% (9/146)
Weight loss 4.1% (6/146)
Other 8.9% (13/146)
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age was 65 years for both groups (p=0.400). Re-
garding the non-responder group, 48% had a lo-
cally advanced disease (pT3-4) (responder: 25%, 
p<0.001), and 30% had lymph node infiltration 
during cystectomy (responder: 12%, p<0.001). 
There were no significant differences regarding 
the ratio of high-grade tumours (non-responder: 
90% vs. responder: 86%, p=0.359), metastatic 
disease (9% vs. 9%, p=0.971), and (concomitant) 
carcinoma in situ (39% vs. 48%, p=0.108).
Functional outcome
Median ICIQ-SF within our patient collec-
tive was 10 (1-21). Depending on the respective 
ICIQ-SF scores, incontinence was classified as se-
vere in 44% (n=67) of our study group. Regarding 
pad usage, 40% (n=61) were in need of more than 
2 pads daily. Incontinence results are summarized 
in Table-2.
Data concerning sexual function was 
available for 126 out of 133 male patients and 
for 15 out of 19 female patients. Analysis of 
the respective IIEF-5 scores showed a median 
IIEF-5 of 3 (1-24) within our study collective. 
Regarding the female patients, median FSFI-6 
was 4 (1-20). Sexual function results are sum-
marized in Table-2.
Univariate analysis of prognostic features for 
health-related QoL
Preoperative characteristics
At median follow-up, overall health-re-
lated QLQ-C30 was 75 for male patients and 67 
for female patients (p=0.019). Patients with less or 
equal 71 years (median age of the patient collec-
tive) had a median QLQ-C30 of 69, whereas pa-
tients older than 71 years had a median score of 
74 (p=0.784). Analysing patient’s age continuous-
ly using Spearman’s correlation, we found no sta-
tistically significant impact on the respective QoL 
(p=0.926). Regarding the preoperative performan-
ce status, we found patients with a preoperative 
ECOG score of 0 having a significantly higher QoL 
compared to patients with a preoperative ECOG 
score of 1 or 2 (p<0.001 respectively, Figure-1A).
Intraoperative characteristics
QoL for patients whose cystectomy was per-
formed by an experienced surgeon (>100 previous 
Table 2 - functional outcome following radical cystectomy and orthotopic urinary diversion after a median follow-up of 48 months.
IcIQ-sf at follow-up
 Median 10 (range 4 to 21)
severity of incontinence based on IcIQ-sf
Mild (1 - 5) 16.4% (25/152)
Moderate (6 - 10) 37.5% (57/152)
Severe (>10) 44.1% (67/152)
Dry 2.0% (3/152)














IcIQ-sf = International Consultation on Incontinence Questionnaire short-form; IIEf-5 = International Index of Erectile Function; fsfI-6 = abridged Female Sexual 
Function Index
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radical cystectomies) had a median QLQ-C30 score 
of 83 whereas patients whose radical cystectomies 
were performed by a less experienced surgeon 
(<100 previous radical cystectomies) had a median 
QLQ-C30 score of 74 (p=0.186, Figure-1B). Howe-
ver, when using the predefined cut-off value, 53% 
(experienced) vs. 35% (less experienced) of the pa-
tients had a QLQ-C30 score of >70 (p=0.019).
A nerve-sparing radical cystectomy was 
performed in 77 of 152 patients (50.7%). If a 
nerve-sparing operation was performed, median 
postoperative QoL was significantly increased 
(QLQ-C30 82 vs. 69; p=0.001, Figure-1C). 64% of 
the nerve-sparing group had a QLQ-C30>70 (vs. 
36%, p<0.001).
There were no statistical significances re-
garding intraoperative complications (44 vs. 50% 
QLQ-C30≥70, p=0.731), postoperative complica-
tions (49 vs. 51%, p=0.744), need for perioperative 
blood transfusion (36 vs. 53%, p=0.116), intraope-
rative blood loss (<500mL: 55% QLQ-C30≥70 vs. 
≥500mL: 47%, p=0.355), and the operation dura-
tion (median operation time: 217 minutes; <217 
minutes: 58% QLQ-C30≥70 vs. 43%, p=0.077).
Regarding the pathological tumour stage, 
patients with locally advanced disease (pT3-4) as 
well as patients with lymph node involvement did 
not have statistically significant different QLQ-
-C30 scores than those with limited disease as well 
as without lymph node involvement (p=0.760, 
p=0.632 respectively).
Postoperative time course and adjuvant the-
rapies
Regarding the postoperative time course, 
we found no statistically significant differences 
when comparing patient’s QOL after 3 months, 
6 months, 9 to 12 months, 1 year, 2 to 3 years, 
4 to 5 years, and more than 5 years postope-
ratively. In detail, patients who were analysed 
during their first year of follow-up had a median 
QLQ-C30 of 67 (39% QLQ-C30≥70); patients who 
were analysed after more than one year postope-
ratively had a median score of 75 [p=0.078 (53% 
QLQ-C30≥70, p=0.168)].
Adjuvant systemic chemotherapy or pallia-
tive chemotherapy due to tumour recurrence was 
performed in 19 of 152 patients (12.5%). Median 
QLQ-C30 score for those patients was 67 (vs. 82 if 
no chemotherapy was performed, p=0.04). Among 
the patients who underwent chemotherapy, 33% 
had a QLQ-C30 of ≥70 (vs. 52%, p=0.174). There 
was no significant difference if the chemotherapy 
was performed within the last 12 months befo-
re answering the questionnaire, or more than 12 
months ago (p=0.635).
During the postoperative time course, ra-
diotherapy was performed in 5 of 152 patients 
(3.9%). Median QLQ-C30 was 77 if no radiothe-
rapy was performed, and 41 if radiotherapy was 
performed (p=0.006). None of the patients who 
underwent radiotherapy reached a QLQ-C30 score 
of ≥70 (p=0.02).
In total, 19 patients (12.5%) suffered from 
recurrence of their malignancy. There was no sta-
tistically significant difference when comparing 
these patients with those patients without recur-
ring disease (41% QLQ-C30≥70 vs. 52%, p=0.462).
Patients who were symptomatic at the 
time of follow-up had a significantly lower 
QoL than those being asymptomatic (p=0.006, 
Figure-1D). In detail, patients suffering from 
weight loss had a significantly lower QoL than 
asymptomatic ones (p=0.003) whereas patients 
with night sweats as well as flank pain did not 
(p=0.076, p=0.214 respectively). The symptoma-
tic as well as asymptomatic patients did not di-
ffer in terms of disease extent and lymph node 
involvement (p=0.800). Among the asymptoma-
tic patients, 60% had a QLQ-C30 of ≥70 (symp-
tomatic patients: 34%, p=0.003).
Functional outcome
Addressing the potential impact of incon-
tinence, we found a median QLQ-C30 of 69 for 
daytime incontinence and a median QLQ-C30 of 
82 for daytime continence (p<0.001, Figure-1E). 
Impact of severity of incontinence was analysed 
based on daily pad usage [0-1 pad (83) vs. >2 pads 
(65), p<0.001, Figure-1F], and based on the ICIQ-SF 
[dry/mild incontinence (median QLQ-C30: 83) vs. 
moderate incontinence (83) vs. severe incontinen-
ce (67), p<0.001, Figure-1G]. Continuous analysis 
of the respective ICIQ-SF scores confirmed our pri-
mary results (p>0.001, Figure-2). Among the dry 
patients as well as patients with mild incontinen-
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figures 1 A-h – univariate analysis of multiple predefined prognostic features on postoperative QoL after radical 
cystectomy and orthotopic urinary diversion.
A p value <0.05 was considered statistically significant (EcOg=Eastern Cooperative Oncology Group performance status score; IcIQ-sf=International Consultation on 
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ce, 69% had a QLQ-C30 score of ≥70 (moderate 
incontinence: 66%, severe incontinence: 28%; 
p<0.001). In line, 65% of the patients in need of 
0-1 pads per 24h had a QLQ-C30 score of ≥70 (2 
pads: 62%, >2 pads: 30%; p<0.001). Among the 
patients that achieved daytime continence, 61% 
had a QLQ-C30 score of ≥70 (no daytime con-
tinence: 28%, p<0.001). Patients suffering from 
urinary urgency had a median QLQ-C30 of 70, 
whereas patients with no urgency symptoms had 
a median score of 82 (p=0.015). Regarding the 
predefined cut-off values, 28% of the patients 
suffering from urinary urgency achieved a QLQ-
-C30 score of ≥70 (no urgency symptoms: 55%, 
p=0.007).
Analysis of sexual outcome revealed a 
significant influence of IIEF-5 [<20 (median 
QLQ-C30: 75) vs. >20 (83), p=0.045, Figure-
-1H], but not of FSFI-6 (FSFI-6≤18 vs. FSFI>18; 
p=0.800). The patient subgroup that skipped the 
IIEF-5 questionnaire did not differ statistically 
significant in age (p=0.786) as well as ICIQ-SF 
(p=0.863) to those who answered the question-
naire. Among the patients with an IIEF-5 score 
of 20-25, 86% achieved a QLQ-C30 score of ≥70 
(<20: 51%, p=0.078).
Multivariate analysis of prognostic features for 
health-related QoL
In a last step, a multivariate analysis was 
performed using a multiple logistic regression mo-
del. Hereby, all prognostic features that had statis-
tically significant results in the univariate analysis 
were included. In detail, independent prognostic 
relevance could be confirmed for preoperative 
ECOG performance status of 0 (p=0.020 vs. ECOG 
1, p=0.047 vs. ECOG 2), the experience of the res-
pective surgeon (≥100 vs. <100 previous cystecto-
mies, p=0.021), and daytime continence (p=0.032). 
Results of the multivariate analysis are summari-
zed in Table-3.
DIscussIOn
Orthotopic ileal neobladder has become a 
widespread treatment of muscle-invasive blad-
der cancer. Certainly, complication rates are still 
high and functional outcomes may be unfavou-
rable even in high-volume centres (15-18). As a 
consequence, recently more attention was drawn 
towards health-related QoL after radical cystec-
tomy (6). However, measurement of QoL remains 
difficult and requires specific tools to address 
figure 2 - Impact of patient’s IcIQ-sf score on health-related quality of life based on EORTc QLQ-c30 global health status 
using spearman’s rank correlation. A p value <0.05 was considered statistically significant (QOL=quality of life).
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health-related QoL aspects adequately. A various 
number of different existing instruments-gene-
ric, cancer specific and bladder cancer specific-
-complicate the comparison and integration of 
the pre-existing literature (19). We used the vali-
dated EORTC QLQ-C30 that has been frequently 
used in multiple studies investigating QoL af-
ter radical cystectomy (20-27). In recent years, 
many efforts have been made to define certain 
cut-off values in order to select those patients 
with unmet needs for further support. Snyder et 
al. evaluated more than 500 oncologic patients 
and found a QLQ-C30 global health status cut-
-off value of 70 to have a sensitivity of up to 
86% and a negative predictive value of up to 
94% (14, 28). The aim of the current study was 
to evaluate various potential prognostic features 
on patients QoL after orthotopic urinary diver-
sion, focusing on preoperative, perioperative as 
well as postoperative features. To allow a better 
comparison with existing literature, we analysed 
the postoperative QLQ-C30 global health status 
as a continuous parameter as well as following 
Snyder et al. (14).
Addressing patient-derived features, 
we found no statistically significant impact of 
preoperative patient’s age. This finding is in line 
with recent publications indicating that radical 
cystectomy with orthotopic urinary diversion 
can be safely performed even in elderly patient 
cohorts (29). Imbimbo et al. even found significant 
increased QLQ-C30 scores in patients older than 
65 years (30). However, there is also evidence 
that elderly patients are still less likely to receive 
orthotopic urinary diversion (31). Going further, 
we found a significant impact of the preoperative 
performance status on postoperative QoL in 
univariate as well as in multivariate analysis. Given 
the fact that health-related QoL measurements 
take into consideration multiple aspects including 
physical status, general health and social 
interaction, it seems intuitive that patients with 
a better performance status profit more from a 
procedure that aims to allow an unaltered, active 
lifestyle. In line, it has been shown that patients 
undergoing orthotopic urinary diversion are 
more active and have a better physical function 
compared to patients undergoing incontinent 
urinary diversion (32). Our observations indicate 
that age per se is not associated with impaired QoL 
after orthotopic urinary diversion and discussion 
of QoL aspects prior to radical cystectomy should 
Table 3 - Multivariate analysis of prognostic features that showed significant results in univariate analysis. 
Prognostic feature P value OR 95% CI
Gender [male/female] 0.185 2.745 0.618 12.193
ECOG 1 vs. 0 0.020 0.336 0.134 0.842
ECOG 2 vs. 0 0.047 0.121 0.015 0.974
ICIQ group mild vs. moderate 0.394 1.76 0.48 6.449
ICIQ group mild vs. severe 0.382 0.504 0.109 2.342
Surgeon experience <100 vs. >100 prev. rCx [y/n] 0.021 3.442 1.203 9.847
Nerve-sparing [y/n] 0.165 2.029 0.747 5.511
Radiation therapy [y/n] 0.999 0 0 .
Symptoms [y/n] 0.109 0.458 0.176 1.192
Urge [y/n] 0.259 0.486 0.139 1.702
Daytime continence [y/n] 0.032 3.131 1.101 8.908
Daily pad usage 2 vs. 0-1 0.817 0.859 0.238 3.105
Daily pad usage >2 vs. 0-1 0.995 0.996 0.274 3.616
cI = confidence interval; EcOg = Eastern Cooperative Oncology Group performance status score; IcIQ = International Consultation on Incontinence Questionnaire; OR = 
odds ratio; rcx = radical cystectomy.
A p value >0.05 was considered statistically significant.
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be based on the patient’s performance status 
rather than on the respective patient’s age. 
Regarding preoperative patient selection, our 
results indicate, that elderly patients who have an 
adequate performance status, can be treated with 
an orthotopic urinary diversion and still have a 
good postoperative QoL. Since radical cystectomy 
for octogenarians becomes more accepted, this 
finding has important clinical implications (33).
In the current study, various intraopera-
tive characteristics on the patient’s postoperative 
QoL were analysed, indicating a significant impact 
of the surgeon’s experience both in univariate as 
well as in multivariate analysis. To our know-
ledge, evidence regarding the surgeon’s learning 
curve impact on patients postoperative QoL after 
radical cystectomy and orthotopic urinary diver-
sion is still very limited. However, there is evi-
dence that excellent functional outcomes can be 
achieved in high-volume centers (18). In line, it 
has been shown that the surgeon’s individual lear-
ning curve has a significant impact on functional 
outcome after radical prostatectomy and is there-
fore directly affecting the patient’s postoperative 
QoL (34). The impact of surgeon’s experience on 
postoperative QoL after orthotopic urinary diver-
sion might highlight the importance of the referral 
to high-volume centers and therefore has clinical 
implications.
Addressing a potential time course of 
patient’s QoL after orthotopic urinary diversion, 
we found no statistically significant differences 
in QoL after the respective moments of follow-up. 
However, there was a statistical trend favouring 
those patients who were evaluated more than 1 
year postoperatively. This might indicate that QoL 
increases during the postoperative course of time 
as described by Kulaksizoglu and colleagues (27). 
We found that, if patients underwent adjuvant 
or palliative chemotherapy or radiotherapy, QoL 
was significantly lower, no matter if the respec-
tive therapy was performed within 1 year before 
answering the questionnaires or not. It has to be 
stated, however, that there might be a relevant 
non-responder bias in our patient cohort. Thus, 
these findings have to be interpreted with cau-
tion. Our results are partly in line with the fin-
dings of Cognetti et al. who also found a decline 
of QoL after initiation of adjuvant Cisplatin-ba-
sed chemotherapy. However, the authors stated 
that there was a subsequent improvement after 
the initial decline of QoL, which is not reflected 
by our data (35).
To assess the impact of urinary inconti-
nence on health-related QoL, we used the vali-
dated ICIQ-SF questionnaire and pad usage and 
found a significant impact of urinary leakage. 
These findings are in line with the results of Take-
naka et al. who evaluated long-term outcome in 
QoL after orthotopic neobladder in 86 patients and 
found worse QoL scores in patients with daytime 
incontinence (36). Zahran et al. analyzed QoL of 
74 women after radical cystectomy and orthotopic 
neobladder using QLQ-C30 and observed a signi-
ficant negative impact of incontinence (7). In line 
with Imbimbo et al., we found urinary inconti-
nence being an independent prognostic feature of 
an impaired QoL (30). However, the findings of 
the current study addressing the great impact of 
continence are based on multiple consistent pa-
rameters in a contemporary patient collective and 
therefore add important information to the exis-
ting literature.
It is commonly accepted that a signifi-
cant proportion of patients after orthotopic bla-
dder replacement suffer from sexual dysfunction 
(37). In our patient collective, for instance, only 
5.6% of the men could be classified as “no sexual 
dysfunction” based on the respective IIEF-5 score 
(>20). Since no preoperative data was available, 
these results have to be interpreted with caution. 
However, we were able to show that health-rela-
ted QoL was significantly increased in those pa-
tients who had a postoperative IIEF-5 score of 
more than 20. To date, there is only limited data 
concerning the impact of sexual function on QoL 
after radical cystectomy. Studies from large pros-
tate cancer series, on the other hand, consisten-
tly report better QoL outcomes for nerve-sparing 
radical prostatectomies indicating a major impact 
of sexual preservation on QoL aspects after major 
pelvic surgery (38). Summarizing, our findings 
highlight the great impact of functional aspects 
on health-related QoL. However, it is somewhat 
difficult to imply the important role that pos-
toperative continence plays for health-related 
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QoL into daily clinical practice. Naturally, every 
surgeon tries to achieve the best possible func-
tional result. However, one might focus on the 
development of continence-preserving technical 
modifications. Regarding radical prostatectomy 
for example, the posterior rhabdomyosphincter 
reconstruction, also known as Rocco stitch, has 
been proposed to improve postoperative conti-
nence (39, 40). Additionally, we still lack kno-
wledge how the shape of the neobladder (e.g. 
U- vs. W-shape) affects postoperative continen-
ce recovery.
Certainly, our study is not devoid of li-
mitations. Major drawback is its retrospective 
nature with all the known limitations that are 
inherent. The current study is a cross-sectional 
study and QoL has not been measured at speci-
fic time-points. Nevertheless, the current study 
provides QoL analyses from various different 
follow-up periods, providing a possible idea of 
the natural process of QoL after radical cystec-
tomy. In the current study, the EORTC QLQ-C30 
global health status was used. It has to be sta-
ted, that, unlike the EORTC QLQ-BLM30, this 
questionnaire is not bladder cancer specific and 
lacks additional information regarding body 
image, urostomy problems, and use of catheters. 
The QLQ-BLM30 has been used in several pu-
blications before, but is still not validated (23, 
26, 41). Additionally, the Functional Assessment 
of Cancer Therapy-General, Bladder (FACT-BL) 
and Vanderbilt Cystectomy Index (FACT-VCI) 
are validated bladder cancer specific question-
naires that have been used in health-related QoL 
studies before (42). However, in a recent meta-
-analysis including data from 18 studies that in-
vestigated health-related QoL after radical cys-
tectomy, 10 out of 18 used the EORTC QLQ-C30 
questionnaire (43). This indicates, that, despite 
being not cancer specific, the QLQ-C30 questio-
nnaire is well established in QoL analyses of pa-
tient cohorts that underwent radical cystectomy 
and orthotopic urinary diversion.
cOncLusIOns
The current study analyses the impact of 
multiple potentially prognostic features on QoL 
after orthotopic urinary diversion. We report he-
alth-related QoL outcomes in a contemporary pa-
tient cohort. Hereby, we were able to show that 
preoperative ECOG status, surgeon experience and 
daytime incontinence are independent prognostic 
features for a good postoperative QoL.
ABBREvIATIOns
QoL = Quality of life
QLQ-C30 = Quality of life questionnaire C30
EORTC = European Organization for Research on 
Treatment of Cancer
ICIQ-SF = International Consultation on Inconti-
nence Questionnaire short-form
IIEF-5 = International Index of Erectile Function
FSFI-6 = Female Sexual Function Index (abrid-
ged)
FACT-BL = Functional Assessment of Cancer The-
rapy-General, Bladder
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